We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
David Maron

David J. Maron MD, FACC, FAHA

C.F. Rehnborg Professor of Medicine; Chief, Stanford Prevention Research Center; Director, Preventive Cardiology, Stanford University School of Medicine, Stanford, California

Dr. Maron is the C.F. Rehnborg Professor of Medicine at Stanford University School of Medicine where he serves as Chief of the Stanford Prevention Research Center and Director of Preventive Cardiology.

Dr. Maron is a cardiologist who has conducted clinical trials of secondary prevention of coronary artery disease. He was a member of the team that designed the COURAGE trial, which examined the impact of adding PCI to guideline-directed medical therapy in patients with stable coronary disease. He was co-chair and principal investigator of the ISCHEMIA trial, an NIH-funded study that tested the benefits of cardiac catheterization and revascularization added to guideline-directed medical therapy in 5,000 patients with stable coronary artery disease and at least moderate ischemia.

Disclosures

Dr. Maron has no relevant disclosures.